F2 Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

F2 Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2023	ElevateBio	$400.0M Series D	AyurMaya, Matrix Capital Management	MPM Capital, RA Capital, EcoR1 Capital, EDBI, Emerson Collective, Fidelity Management & Research Company, Khalil Barrage, Lee Family Office, Karina Thorn, R&D partner, Redmile Group, Samsara BioCapital, SoftBank, Surveyor Capital, Vertex Ventures, Woodline Partners
May 1, 2023	ReNAgade Therapeutics	$300.0M Series A	MPM Capital, F2 Ventures	Creacion Ventures
May 1, 2021	Parametrix Insurance	$28.0M Series A	FirstMark Capital	Ambridge Capital, Curie.Bio, F2 Capital, Gradient Ventures, Operator Partners, Christian Reber, Lucas Cranach, Martin Sinner, Moshe Lichtman, Stephan Schambach, Vivek Garipalli, Jonathan Saacks
Feb 1, 2021	Orna Therapeutics	$80.0M Series A	MPM Capital, Morana Jovan-Embiricos, Sakae Asanuma	Abingworth, ARCH Venture Partners, Atlas Venture, Hakan Goker, Seroba Life Sciences, Taiho Ventures, Astellas Venture Management, Bristol Myers Squibb, Francesco Marincola, Novartis Institutes for Biomedical Research, PagsGroup
Dec 17, 2020	Cullinan Therapeutics	$131.2M Series C	Foresite Capital	Baupost Group, Boxer Capital, BVF Partners, Cowen Healthcare Investments, Eventide Asset Management, Leerink Partners, Logos Capital, MPM Capital, Nextech Invest, OrbiMed, Rock Springs Capital, Schooner Capital, Venrock
Jun 4, 2020	Cullinan Therapeutics	$98.5M Series B	—	Jon Wigginton, MD
Mar 30, 2020	ElevateBio	$170.0M Series B	—	EcoR1 Capital, Swee Yeok CHU, PBM, Invus, MPM Capital, Redmile Group, Samsara BioCapital, Surveyor Capital, Vertex Ventures
May 13, 2019	ElevateBio	$150.0M Series A	Morana Jovan-Embiricos, Ansbert Gadicke	Oleg Nodelman, Redmile Group, Samsara BioCapital
Mar 18, 2019	TriNetX	$40.0M Series D	Joe Volpe	Deerfield Management, Itochu Technology Ventures, MPM Capital
Mar 1, 2018	TCR2	$130.0M Series B	Li Wei, Curative Ventures	Creacion Ventures, MPM Capital, Osage University Partners, Alexandria Venture Investments, ArrowMark Partners, Cathay Fortune Capital Investment, Haitong International, Hillhouse Capital Group, Lucion Group, Mirae Asset, Redmile Group, Sirona Capital, Syno Capital
Oct 3, 2017	Cullinan Therapeutics	$150.0M Series A	F2 Ventures, UBS	—